NUGoKidney 2021 Year in Review
As another year of challenge and change winds down, we're taking a look back at some of our favorite moments and achievements from the past year. We’re so grateful for all of you - none of this would have been possible without your support. We look forward to connecting with you in 2022!
NUGoKidney continues to support groundbreaking discoveries and advances in kidney research
NUGoKidney continued to support investigators and clinicians in kidney disease research with resources and services that further our mission to identify, test, and advance the development of novel therapeutics for patients with kidney diseases. This year, the Center supported 34 investigators and was acknowledged in 26 publications.
One study from Pilot & Feasibility awardee, Jing Jin, MD, PhD, invented a new radiopharmaceutical for noninvasive imaging of kidney lesions. While another study by Feinberg Associate Professor, Sook Hyeon Park, MD, won first place in the CJASN Trainee Competition for her findings on donor-derived cell-free DNA & gene expression. Two-time Pilot and Feasibility awardee, Jennie J Lin, MD, MTR, received the American Society of Nephrology (ASN) 2021 Carl W. Gottschalk Research Scholar Grant. The awarded project titled, Endoplasmic Reticulum Stress and Macrophage Function in APOL1 Nephropathy, studies how genetic variants modulate macrophage function at the intersection of kidney and cardiovascular disease.
Research teams led by Daniel Batlle, MD and Pinelopi Kapitsinou, MD, received NUCATS COVID-19 Collaborative Innovation Awards, which funded new interdisciplinary research and collaboration projects on COVID-19 and the kidney. Dr. Batlle and his team’s research on soluble ACE2 proteins for COVID-19 also continues to be cited and has shown some exciting preliminary results for developing effective COVID-19 treatments.
NUGoKidney researchers also received recognition for their numerous research contributions. NUGoKidney Director, Susan Quaggin, MD, FASN, was elected fellow of the National Academy of Inventors (NAI) for her prolific innovations that have made an impact on the quality of life, specifically for her discovery of vascular signaling pathways essential for the development of specialized vessels in kidneys. Guillermo Oliver, director for NUGoKidney’s Preclinical Models Core and FCVRI Center for Vascular and Developmental biology, received the 2021 Earl P. Benditt Award in recognition of his numerous contributions to our understanding of the cell biology of the lymphatic system.
Interested in collaborating with NUGoKidney in 2022? Request a consultation to learn more about how we can support your kidney research.